SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

Abroad (travel likely)RecruitingPHASE4

Conditions

Gout and Hyperuricemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Hyon K Choi, MD) · hchoi@mgh.harvard.edu · 6177265650

Study leads

Hyon K Choi, MD, DrPH
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Acute Gout Flare · Gout Attack · Gout Flare

IsraelRecruitingPHASE2, PHASE3

Birmingham, United States · Glendale, United States

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

Gout

IsraelRecruitingPHASE2

Little Rock, United States · El Cajon, United States

A Study of Dotinurad Versus Allopurinol in Participants With Gout

Gout

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Primary Gout and Hyperuricemia

Abroad (travel likely)RecruitingPHASE2

Shanghai, China